These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 22120844)
1. A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours. Schofield L; Grieu F; Goldblatt J; Amanuel B; Iacopetta B Fam Cancer; 2012 Mar; 11(1):1-6. PubMed ID: 22120844 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
3. Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test. Alqahtani M; Grieu F; Carrello A; Amanuel B; Mashour M; Alattas R; Alsaleh K; Alsheikh A; Alqahtani S; Iacopetta B Asian Pac J Cancer Prev; 2016; 17(4):1917-23. PubMed ID: 27221876 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
5. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M Tumori; 2014; 100(3):315-20. PubMed ID: 25076244 [TBL] [Abstract][Full Text] [Related]
6. Population-based screening for Lynch syndrome in Western Australia. Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394 [TBL] [Abstract][Full Text] [Related]
7. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. Toon CW; Walsh MD; Chou A; Capper D; Clarkson A; Sioson L; Clarke S; Mead S; Walters RJ; Clendenning M; Rosty C; Young JP; Win AK; Hopper JL; Crook A; von Deimling A; Jenkins MA; Buchanan DD; Gill AJ Am J Surg Pathol; 2013 Oct; 37(10):1592-602. PubMed ID: 23797718 [TBL] [Abstract][Full Text] [Related]
8. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526 [TBL] [Abstract][Full Text] [Related]
9. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community. Schofield L; Goldblatt J; Iacopetta B Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
11. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Schofield L; Watson N; Grieu F; Li WQ; Zeps N; Harvey J; Stewart C; Abdo M; Goldblatt J; Iacopetta B Int J Cancer; 2009 Mar; 124(5):1097-102. PubMed ID: 19072991 [TBL] [Abstract][Full Text] [Related]
12. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer. Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738 [TBL] [Abstract][Full Text] [Related]
14. Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer? Marabelli M; Gandini S; Rafaniello PR; Calvello M; Tolva G; Feroce I; Lazzeroni M; Marino E; Dal Molin M; Trovato C; Guerrieri-Gonzaga A; Petz WL; Barberis M; Bertario L; Bonanni B Dig Liver Dis; 2020 Dec; 52(12):1503-1511. PubMed ID: 32620519 [TBL] [Abstract][Full Text] [Related]
15. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164 [TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. Leenen CH; van Lier MG; van Doorn HC; van Leerdam ME; Kooi SG; de Waard J; Hoedemaeker RF; van den Ouweland AM; Hulspas SM; Dubbink HJ; Kuipers EJ; Wagner A; Dinjens WN; Steyerberg EW Gynecol Oncol; 2012 May; 125(2):414-20. PubMed ID: 22306203 [TBL] [Abstract][Full Text] [Related]
18. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics. Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M; Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553 [TBL] [Abstract][Full Text] [Related]
19. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing. Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016 [TBL] [Abstract][Full Text] [Related]
20. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]